Friday, March 13, 2026
32.6 C
Bengaluru

If Strategy is Commodity, How Can Organisations Ensure Differentiation?

If Strategy is Commodity, How Can Organisations Ensure Differentiation?

Strategy and strategic planning are perhaps the most hyped-up words in business. One approaches strategy, as if entering the sanctum sanctorum of business management, thanks to business gurus and management consultancies that sell permutations and combinations of the same strategies to as many companies as their business development team manages to hook.

This lesser known quote on strategy by Peter Drucker, made me delve into the topic a bit. While many business gurus have given different versions, I liked the simpler and saner version by Srinivas Khandula, a delightful speaker, who I chanced upon and listened to, at an NHRD event on human resource management.

According to Khandula, strategy is, “Anything you want to do in a particular way.” Khandula further elaborates saying, “Most companies tend to relook their strategies when things don’t work as envisaged, instead of critically assessing the execution culture of their organisation.”

Execution is an art because it involves people and often hundreds and thousands of people as in pharma companies, where the Field Force is doing the same thing day in and day out. What matters is, “How well are they executing?” Is there some coherence in their everyday actions across the country as well as scope for variations to suit local market conditions and individual strengths? Are front-line managers able to nurture and build a culture of excellence? How much does the company invest in the learning and development of front-line managers? Are the front-line managers able to manage business, lead people and build relationship with customers?

Mankind Pharma is a great example of “strategy is a commodity but execution is an art” because they have taken a mundane strategy of low priced drugs and created a culture where people are valued for their inherent strengths.

And what an art they have made out of it.

Hot this week

IPM Powers Ahead in 2026: 11% Growth Fueled by Cardiac, Anti-Diabetics, and GLP-1 Stars

India's pharmaceutical market charged into 2026 with strong momentum,...

Material Testing Market Share, Global Industry Size, Trends, Technology, and Analysis by 2035

Roots Analysis recently published a report on the global Material...

How Smart Medical Reps Can Beat Bots

Today's Brand Equity cover — a woman lost in...

Nutraceuticals: Health, Hope Or Hype?

Walk into almost any clinic today and you will...

When Biology Beats Willpower: The Rise of GLP‑1/GIP Therapies

“Lifestyle advice often asks patients to fight powerful evolutionary...

Topics

Material Testing Market Share, Global Industry Size, Trends, Technology, and Analysis by 2035

Roots Analysis recently published a report on the global Material...

How Smart Medical Reps Can Beat Bots

Today's Brand Equity cover — a woman lost in...

Nutraceuticals: Health, Hope Or Hype?

Walk into almost any clinic today and you will...

When Biology Beats Willpower: The Rise of GLP‑1/GIP Therapies

“Lifestyle advice often asks patients to fight powerful evolutionary...

The Antifungal Blind Spot: India’s Quiet Clinical Crisis

A market analysis and clinical commentary on the growing...

Elephant in the Doctor’s Clinic: Indian Pharma Medical Rep

For decades, the Medical Representative has been the backbone...
spot_img

Related Articles

spot_imgspot_img